Toggle light / dark theme

AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.

In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.

The antibody therapy called AZD7442 could protect people who do not have a strong enough immune response to COVID-19 vaccines or to supplement a vaccination course for those, such as military personnel, who need to booster their protection further, AstraZeneca has said.


AstraZeneca said its late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.

King County stated that a a female resident in her late 30’s had died from the “very rare” complication. The unnamed resident received her J&J shot on August 26.


A county in Washington on Tuesday confirmed that a woman died from blood-clotting complications after receiving Johnson & Johnson’s single-dose COVID-19 vaccine. She is believed to be the fourth person to have died from such a complication.

King County stated that a female resident in her late 30s had died from the “very rare” complication. The unnamed resident received her J&J shot Aug. 26.

“Her cause of death was determined to be thrombosis with thrombocytopenia syndrome (TTS), a condition that has been identified as a rare but potentially serious adverse event in people who received the J&J vaccine,” the county said in a statement.

I hope we get the hologram interfaces depicted too.


It’s becoming clear that aging is just as curable as other diseases such as the cold or a broken bone. Advancements in biotechnology now allow for targeted gene therapy and supplements to be invented that can both stop aging and even reverse the aging process through new Longevity Technology. The field of Longevity has expanded and evolved a lot during the past few years and have invented new treatments for diseases of old people which could increase the average lifespan of people by a ton according to the leading scientists such as David Sinclair and Aubrey De Grey. Anti Aging Supplements such as Metformin and NAD+, NMN are just the start.

Every day is a day closer to the Technological Singularity. Experience Robots learning to walk & think, humans flying to Mars and us finally merging with technology itself. And as all of that happens, we at AI News cover the absolute cutting edge best technology inventions of Humanity.

If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile

The availability of data can paralyze a company and its effort to bring software-centric products and services to market. To solve this issue, two-year-old data startup Rendered.ai is generating synthetic data for the satellite, medical, robotics and automotive industries.

At its most broad, synthetic data is manufactured rather than gathered from the real world. “When we use the term synthetic data what we really mean is engineered simulated datasets, and in particular, we focus on a physics-based simulation,” Rendered.ai CEO Nathan Kundtz explained in a recent interview with TechCrunch.

Kundtz received his PhD in physics from Duke University and cut his teeth in the space industry, heading the satellite antenna developer Kymeta Corporation. After leaving that company, he started working with other small space companies, when he noticed what he called a “chicken and egg” problem.

Driving this revolution has been a new breed and wave of founders and startups that merge the worlds of technology and bio — importantly, not just the old world of biotech (or a narrow definition of tech in bio as only “digital health”), but something much broader, bigger, and blending both worlds. In short, biology — enabled by technology — is eating the world. This has not only changed how we diagnose, treat, and manage disease, but has been changing the way we access, pay for, and deliver care in the healthcare system. It is now entering into manufacturing, food, and several other industries as well. Bio is becoming a part of everything.

This new era of industrialized bio — enabled by AI as well as an ongoing, foundational shift in biology from empirical science to more engineered approaches — will be the next industrial revolution in human history. And propelling it forward is an enormous new driving force, the novel coronavirus SARS-CoV-2, its ever-evolving strains, and the resulting COVID-19 disease pandemic and response — which I believe is analogous to our generation’s World War II (WW2). In other words: a massive global upheaval, but that later led to unprecedented innovation and significant new players.

As a result, we will now see the emergence of bio’s version of GAFA — playing off the “Google Amazon Facebook Apple” of the leading companies in computing, social, mobile — but for bio. And with it, a post-WW2/ post-Covid “Industrial Bio Complex”.

Although the idea of having a small device implanted in our skulls might sound terrifying to some, deep brain stimulation has had a successful past in other brain disorders such as Parkinson’s disease and epilepsy.


Depression can be a frighteningly relentless condition. Luckily, researchers around the world are constantly working on new treatment options, such as a newly designed brain implant for resistant depression.

Altogether, up to a third of people with depression don’t respond or become resistant to treatment. No medication or therapy type seems to help. For those with such treatment-resistant depression, the future can look especially bleak.

AstraZeneca said on Tuesday that it had asked the Food and Drug Administration to grant emergency authorization for an antibody treatment to prevent Covid-19 in people who are at high risk of the disease. If authorized, it would become the first such preventive treatment to be available in the United States, the company said.

The company said in a statement that the treatment had reduced the risk of symptomatic Covid-19 by 77 percent in a trial in which most participants either had other medical conditions that placed them at greater risk of severe illness or were not producing sufficient antibodies after vaccination.

It said the treatment could be used in conjunction with vaccines in people with weaker immune systems. Other antibody treatments in use in the United States, including one developed by the drug maker Regeneron, have mainly been used to treat people who are already infected with the coronavirus.

“To slow the ongoing loss of animal and plant life in the United States, President Biden signed an executive order in January 2,021 stating his administration’s goal to conserve 30% of U.S. lands and water by 2030. This bold, science-based initiative – America the Beautiful – is the first ever nationwide conservation effort to address both climate change and biodiversity loss.” https://www.futuretimeline.net/images/robot-future-timeline.jpg


The U.S. Fish and Wildlife Service (USFWS) has declared 23 species extinct, due to a combination of development, invasive species, logging and pollution.

The agency is recommending that the species be removed from the Endangered Species Act (ESA), the primary law in the United States for protecting and recovering imperilled organisms and the ecosystems they depend on. For the animals proposed for delisting, the protections of the ESA came too late.

These extinctions highlight the importance of the ESA and efforts to conserve species before declines become irreversible. The circumstances of each also underscore how human activity can drive population decline and ultimately extinction, by contributing to habitat loss, overuse and the introduction of invasive species and diseases. The growing impacts of climate change are anticipated to further exacerbate these threats and their interactions.